Brainstorm Cell Therapeutics Inc (BCLI) — Financial Flexibility Index
Brainstorm Cell Therapeutics Inc (BCLI) has a Financial Flexibility Index of -0.07x as of December 2025. Free cash flow of $-740.00K (operating CF $-740.00K minus capex $0.00) represents 0% of total liabilities ($11.01 Million). Also explore Brainstorm Cell Therapeutics Inc net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Brainstorm Cell Therapeutics Inc Financial Flexibility Index (2001–2025)
Historical Financial Flexibility Index trend for Brainstorm Cell Therapeutics Inc across 25 annual periods. Check Brainstorm Cell Therapeutics Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Brainstorm Cell Therapeutics Inc (2001–2025)
Year-by-year free cash flow to debt coverage for Brainstorm Cell Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Brainstorm Cell Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.63x | $-6.97 Million | $-6.97 Million | $11.01 Million | ▲ +33.1% |
| 2024 | -0.95x | $-9.09 Million | $-9.09 Million | $9.60 Million | ▲ +58.0% |
| 2023 | -2.25x | $-20.44 Million | $-20.46 Million | $9.07 Million | ▼ -34.0% |
| 2022 | -1.68x | $-19.29 Million | $-19.32 Million | $11.47 Million | ▲ +35.5% |
| 2021 | -2.61x | $-25.93 Million | $-26.27 Million | $9.94 Million | ▼ -18.4% |
| 2020 | -2.20x | $-34.81 Million | $-35.19 Million | $15.79 Million | ▼ -283.7% |
| 2019 | -0.57x | $-10.77 Million | $-11.25 Million | $18.76 Million | ▲ +70.3% |
| 2018 | -1.93x | $-12.02 Million | $-12.39 Million | $6.21 Million | ▼ -391.1% |
| 2017 | -0.39x | $-2.18 Million | $-2.36 Million | $5.54 Million | ▲ +94.1% |
| 2016 | -6.66x | $-5.75 Million | $-5.86 Million | $864.00K | ▼ -167.1% |
| 2015 | -2.49x | $-7.36 Million | $-7.41 Million | $2.95 Million | ▼ -86.6% |
| 2014 | -1.34x | $-4.33 Million | $-4.49 Million | $3.24 Million | ▲ +32.7% |
| 2013 | -1.99x | $-3.95 Million | $-4.05 Million | $1.99 Million | ▲ +18.8% |
| 2012 | -2.44x | $-2.83 Million | $-2.92 Million | $1.16 Million | ▼ -41.2% |
| 2011 | -1.73x | $-2.17 Million | $-2.22 Million | $1.26 Million | ▼ -29.9% |
| 2010 | -1.33x | $-2.06 Million | $-2.07 Million | $1.55 Million | ▼ -348.0% |
| 2009 | -0.30x | $-744.00K | $-744.00K | $2.50 Million | ▲ +44.4% |
| 2008 | -0.54x | $-1.58 Million | $-1.73 Million | $2.95 Million | ▼ -31.7% |
| 2007 | -0.41x | $-1.43 Million | $-1.77 Million | $3.51 Million | ▼ -44.5% |
| 2006 | -0.28x | $-714.00K | $-855.00K | $2.54 Million | ▼ -136.6% |
| 2005 | -0.12x | $-1.04 Million | $-1.25 Million | $8.77 Million | ▲ +95.4% |
| 2004 | -2.57x | $-449.28K | $-677.84K | $174.95K | ▼ -693.0% |
| 2003 | -0.32x | $-15.44K | $-15.44K | $47.67K | ▼ -16.0% |
| 2002 | -0.28x | $-7.01K | $-7.01K | $25.13K | ▲ +56.9% |
| 2001 | -0.65x | $-7.44K | $-7.44K | $11.49K | — |